Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	227.54M -11.1%
Revenue (ttm)	168.60M +9.1%
Net Income	4.87M +21.7%
EPS	0.47 +20.5%
Shares Out	10.07M
PE Ratio	48.09
Forward PE	20.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,606
Open	22.60
Previous Close	22.60
Day's Range	21.90 - 22.60
52-Week Range	20.40 - 25.95
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 24, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 343
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2025, EPA:ALERS's revenue was 168.60 million, an increase of 9.08% compared to the previous year's 154.56 million. Earnings were 4.87 million, an increase of 21.69%.